Zhitong Finance App News, Warner Pharmaceuticals (688799.SH) issued an announcement. Recently, Hunan Warner Pharmaceutical Co., Ltd. (“Chiral Drugs”), a wholly-owned subsidiary of the company, received terbutaline sulfate's “Chemical Ingredient Marketing Application Approval Notice” (Notice Number: 2026YS00963) issued by the State Drug Administration and publicized it on the “Original and Auxiliary Package Registration Information” platform of the China Drug Administration (CDE).

Zhitongcaijing · 2d ago
Zhitong Finance App News, Warner Pharmaceuticals (688799.SH) issued an announcement. Recently, Hunan Warner Pharmaceutical Co., Ltd. (“Chiral Drugs”), a wholly-owned subsidiary of the company, received terbutaline sulfate's “Chemical Ingredient Marketing Application Approval Notice” (Notice Number: 2026YS00963) issued by the State Drug Administration and publicized it on the “Original and Auxiliary Package Registration Information” platform of the China Drug Administration (CDE).